GlassScriptPhysician profile
Meghana Chalasani
NPI 1164832259
$5,355.02
in general payments reported to CMS, 2019-2025
31 companies · $721 in 2025
The $721 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $138 · 2021: $410 · 2022: $715 · 2023: $1,310 · 2024: $2,062 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,997 · Education: $95.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,997.26 |
| Education | $95.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $759.06 | 2021-2025 | Farxiga, Lokelma |
| Amgen INC. | $434.76 | 2021-2025 | Krystexxa, Tavneos |
| Travere Therapeutics, INC. | $395.34 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $332.18 | 2021-2025 | Jynarque |
| Vifor Pharma, INC. | $318.50 | 2020-2024 | Veltassa |
| Horizon Therapeutics Plc | $307.88 | 2020-2023 | Krystexxa |
| Calliditas Therapeutics US INC. | $305.97 | 2022-2025 | Tarpeyo |
| Glaxosmithkline, LLC. | $252.99 | 2020-2024 | Benlysta, Jesduvroq |
| Aurinia Pharma U.S., INC. | $245.29 | 2021-2025 | Lupkynis |
| Veloxis Pharmaceuticals, INC. | $219.46 | 2021-2025 | Envarsus |
| Ani Pharmaceuticals, INC. | $207.72 | 2023-2025 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $206.99 | 2021-2024 | Ultomiris |
| Bayer Healthcare Pharmaceuticals INC. | $191.43 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $185.32 | 2020-2023 | Terlivaz |
| Novartis Pharmaceuticals Corporation | $175.24 | 2024-2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $92.53 | 2024-2025 | Rivfloza, Rybelsus, Ozempic |
| Opko Pharmaceuticals, LLC | $90.03 | 2022-2024 | Rayaldee |
| Ultragenyx Pharmaceutical INC. | $89.55 | 2024 | Crysvita |
| Akebia Therapeutics INC | $76.11 | 2024-2025 | Vafseo, Auryxia |
| Lilly USA, LLC | $74.35 | 2024 | Jardiance |
| Ardelyx, INC. | $67.86 | 2024-2025 | Ibsrela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.76 | 2023-2024 | Jardiance |
| Genzyme Corporation | $54.67 | 2022 | |
| Haag-Streit USA, INC. | $39.53 | 2023 | |
| Amicus Therapeutics, INC. | $37.42 | 2021-2023 | Galafold |
| Janssen Pharmaceuticals, INC | $33.28 | 2022 | |
| Kyowa Kirin, INC. | $25.40 | 2025 | |
| Amarin Pharma, INC. | $22.21 | 2021 | |
| Cormedix INC. | $21.23 | 2024 | Defencath |
| Recordati_rare_diseases_inc. | $20.14 | 2023 | Cystadrops |
| Takeda Pharmaceuticals U.S.A., INC. | $17.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghana Chalasani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.